HIF1A and neoplasm: Moreover, inhibitors like PX-478, EZN-2968 and other small molecules targeting HIF1α effectively reduce HIF1α protein levels, contributing to tumor regression and, in some cases, leading to prolonged disease stabilization (100–102).